SNY
$54.35
Revenue | $10682Mn |
Net Profits | $1435Mn |
Net Profit Margins | 13.43% |
Sanofi’s revenue fell -0.56% since last year same period to $10682Mn in the Q2 2023. On a quarterly growth basis, Sanofi has generated -1.67% fall in its revenue since last 3-months.
Sanofi’s net profit jumped 22.13% since last year same period to $1435Mn in the Q2 2023. On a quarterly growth basis, Sanofi has generated -28.07% fall in its net profits since last 3-months.
Sanofi’s net profit margin jumped 22.81% since last year same period to 13.43% in the Q2 2023. On a quarterly growth basis, Sanofi has generated -26.85% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.48 |
EPS Estimate Current Year | 1.48 |
Sanofi’s earning per share (EPS) estimates for the current quarter stand at 1.48 - a 56.98% jump from last quarter’s estimates.
Sanofi’s earning per share (EPS) estimates for the current year stand at 1.48.
Earning Per Share (EPS) | 0 |
Sanofi’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Sanofi has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-10-27 | 1.48 | 0 | -100% |